Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article (16)

Advertisement

Corrigendum Free access | 10.1172/JCI96202

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes

Bon Ham Yip, Violetta Steeples, Emmanouela Repapi, Richard N. Armstrong, Miriam Llorian, Swagata Roy, Jacqueline Shaw, Hamid Dolatshad, Stephen Taylor, Amit Verma, Matthias Bartenstein, Paresh Vyas, Nicholas C.P. Cross, Luca Malcovati, Mario Cazzola, Eva Hellström-Lindberg, Seishi Ogawa, Christopher W.J. Smith, Andrea Pellagatti, and Jacqueline Boultwood

Find articles by Yip, B. in: JCI | PubMed | Google Scholar

Find articles by Steeples, V. in: JCI | PubMed | Google Scholar

Find articles by Repapi, E. in: JCI | PubMed | Google Scholar

Find articles by Armstrong, R. in: JCI | PubMed | Google Scholar

Find articles by Llorian, M. in: JCI | PubMed | Google Scholar

Find articles by Roy, S. in: JCI | PubMed | Google Scholar

Find articles by Shaw, J. in: JCI | PubMed | Google Scholar

Find articles by Dolatshad, H. in: JCI | PubMed | Google Scholar

Find articles by Taylor, S. in: JCI | PubMed | Google Scholar

Find articles by Verma, A. in: JCI | PubMed | Google Scholar

Find articles by Bartenstein, M. in: JCI | PubMed | Google Scholar

Find articles by Vyas, P. in: JCI | PubMed | Google Scholar

Find articles by Cross, N. in: JCI | PubMed | Google Scholar

Find articles by Malcovati, L. in: JCI | PubMed | Google Scholar

Find articles by Cazzola, M. in: JCI | PubMed | Google Scholar

Find articles by Hellström-Lindberg, E. in: JCI | PubMed | Google Scholar

Find articles by Ogawa, S. in: JCI | PubMed | Google Scholar

Find articles by Smith, C. in: JCI | PubMed | Google Scholar

Find articles by Pellagatti, A. in: JCI | PubMed | Google Scholar

Find articles by Boultwood, J. in: JCI | PubMed | Google Scholar

Published September 1, 2017 - More info

Published in Volume 127, Issue 9 on September 1, 2017
J Clin Invest. 2017;127(9):3557–3557. https://doi.org/10.1172/JCI96202.
Copyright © 2017, American Society for Clinical Investigation
Published September 1, 2017 - Version history
View PDF

Related article:

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
Bon Ham Yip, … , Andrea Pellagatti, Jacqueline Boultwood
Bon Ham Yip, … , Andrea Pellagatti, Jacqueline Boultwood
Research Article Hematology Article has an altmetric score of 1

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes

  • Text
  • PDF
Abstract

Mutations of the splicing factor–encoding gene U2AF1 are frequent in the myelodysplastic syndromes (MDS), a myeloid malignancy, and other cancers. Patients with MDS suffer from peripheral blood cytopenias, including anemia, and an increasing percentage of bone marrow myeloblasts. We studied the impact of the common U2AF1S34F mutation on cellular function and mRNA splicing in the main cell lineages affected in MDS. We demonstrated that U2AF1S34F expression in human hematopoietic progenitors impairs erythroid differentiation and skews granulomonocytic differentiation toward granulocytes. RNA sequencing of erythroid and granulomonocytic colonies revealed that U2AF1S34F induced a higher number of cassette exon splicing events in granulomonocytic cells than in erythroid cells. U2AF1S34F altered mRNA splicing of many transcripts that were expressed in both cell types in a lineage-specific manner. In hematopoietic progenitors, the introduction of isoform changes identified in the U2AF1S34F target genes H2AFY, encoding an H2A histone variant, and STRAP, encoding serine/threonine kinase receptor–associated protein, recapitulated phenotypes associated with U2AF1S34F expression in erythroid and granulomonocytic cells, suggesting a causal link. Furthermore, we showed that isoform modulation of H2AFY and STRAP rescues the erythroid differentiation defect in U2AF1S34F MDS cells, suggesting that splicing modulators could be used therapeutically. These data have critical implications for understanding MDS phenotypic heterogeneity and support the development of therapies targeting splicing abnormalities.

Authors

Bon Ham Yip, Violetta Steeples, Emmanouela Repapi, Richard N. Armstrong, Miriam Llorian, Swagata Roy, Jacqueline Shaw, Hamid Dolatshad, Stephen Taylor, Amit Verma, Matthias Bartenstein, Paresh Vyas, Nicholas C.P. Cross, Luca Malcovati, Mario Cazzola, Eva Hellström-Lindberg, Seishi Ogawa, Christopher W.J. Smith, Andrea Pellagatti, Jacqueline Boultwood

×

Original citation: J Clin Invest. 2017;127(6):2206–2221. https://doi.org/10.1172/JCI91363

Citation for this corrigendum: J Clin Invest. 2017;127(9):3557. https://doi.org/10.1172/JCI96202

In Figure 4D, the horizontal axes of the two graphs were labeled incorrectly, and one sentence in the legend for this part was also incorrect. The correct figure part and sentence are below.

Expression of H2AFY isoform 1.1 and the STRAP long isoform in U2AF1S34F and U2AF1WT transduced cells was measured by isoform-specific qRT-PCR relative to the EV control (red bars: erythroid cells; blue bars: granulomonocytic cells).

The authors regret the error.

Footnotes

See the related article at The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.

Version history
  • Version 1 (September 1, 2017): Print issue publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (16)

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 3 X users
79 readers on Mendeley
See more details